BIOMAT Database Logo BIOMAT Database Logo

Selective destruction of human leukemic cells by alkyl-lysophospholipids. 1978

R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008244 Lysophosphatidylcholines Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes one of the fatty acid moieties. Lysolecithin,Lysolecithins,Lysophosphatidylcholine
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder
Destruction of human solid tumors by alkyl lysophospholipids.
June 1980, Journal of the National Cancer Institute,
R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder
Purging murine leukemic marrow with alkyl-lysophospholipids.
December 1984, Blood,
R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder
[Selective photodynamic destruction of leukemic cells].
March 2000, Casopis lekaru ceskych,
R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder
Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance.
February 1983, Cancer research,
R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder
Comparison of selective cytotoxicity of alkyl lysophospholipids.
December 1991, Lipids,
R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder
Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
July 1990, Cancer research,
R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder
Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids.
May 1987, Experimental hematology,
R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder
Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.
August 1985, Experimental hematology,
R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder
Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells.
January 1984, Oncology,
R Andreesen, and M Modolell, and H U Weltzien, and H Eibl, and H H Common, and G W Löhr, and P G Munder
The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells.
August 1984, Experimental hematology,
Copied contents to your clipboard!